Albion News

Albion has announced that it is launching a £25 million share issue for Albion Development VCT plc through a new issue of D shares during Autumn 2009. This is the fourth share issue since Albion Development VCT was launched in 1999. The new D shares will eventually merge with the existing ordinary shares after five years. This is Albion's first fundraising following the management buyout of Close Ventures in January 2009. The fund’s investment strategy is to establish a diversified portfolio of holdings in smaller, unquoted companies, whilst at the same time selecting and structuring... read more
Albion is delighted to announce that it was shortlisted as finalist in the ‘Investors of the Year’ category at the 2009 HealthInvestor Awards. The HealthInvestor Awards ceremony, held on 3rd June 2009 at the Hilton Park Lane, London was attended by 750 industry movers and shakers. The annual awards aim to promote excellence and recognise innovation in the healthcare sector. Albion has a strong track record of investment in the healthcare industry spanning over 13 years, with many successful investment exits such as Careforce Group Plc , Grosvenor Health Group Ltd and Intercare Ltd. We were... read more
Albion announces that it is investing £1.5 million into medical software company Mirada Medical to fund its MBO from Siemens. Mirada has developed software that allows medical images from multiple sources to provide greater clinical accuracy in diagnosis and treatment of medical conditions. Currently, scanning from MRI, CT or PET has specific advantages and disadvantages when imaging certain parts of the body. MRI is good at imaging organs and soft issues but less good at viewing tumours and bones, which a CT scan can show. Mirada’s software enables images from to be fused together to show,... read more
Dexela Limited (London, UK) is pleased to announce that it has entered into an agreement with software developer Three Palm Software (Los Gatos, California) to market its WorkstationOne and CadOneTM software applications globally. In addition, the companies plan to leverage Dexela’s 3D breast imaging technology and expertise (tomosynthesis) in the development of enhanced tomosynthesis workstation functionality and CAD applications. Under the terms of the agreement, Dexela is the exclusive channel for WorkstationOne and CadOneTM in EMEA, Russia and India and will provide marketing and support... read more
Butler Brings Strong Leadership, Vision and Experience to Xceleron Gaithersburg, MD & York, UK – Xceleron, the global leader in predictive clinical research to enable smarter, safer drug development, announced today Michael Butler, Ph.D., has been named President and CEO after an extensive global candidate search. Dr. Butler brings to Xceleron a balance of sales, operations and management know-how, including significant experience in expanding science-driven businesses. “We are pleased to formally introduce Dr. Michael Butler and announce this key appointment. Not only will this move... read more
Close Ventures the leading Venture Capital Trust Manager, is pleased to announce that it has invested £1.5 million into PSE. Close Ventures has now made 16 investments in 2007 with a total value of £40 million. 11 of these were new investments making up £36 million of the total amount invested. PSE was founded 10 years ago as a spin out from Imperial College London and is the creator of market leading gPROMS® process modelling software. gPROMS® is used by process industry organisations to increase profitability by maximising product quality and minimising production cost. In addition, it... read more
Close Venture Management (“Close”) is pleased to announce it has invested £2.0 million in RFI Global Services Limited (“RFI”). Close is the sole investor in RFI, which provides third party testing of sophisticated electronic and wireless devices and sub systems. The investment was made across a number of Close’s funds. Founded in 1987, RFI now operates internationally in three business areas: Cellular, Smart Cards and Wireless Communications. The largest area, Cellular, provides conformance testing services predominantly to the manufacturers of mobile phones. RFI’s clients in this area... read more
Close Venture Management is pleased to announce it has made a £1.5 million investment in Xceleron Limited (“Xceleron”) a contract research company providing specialist services to the pharmaceutical industry. Close was joined in the funding round by Foursome Investments who contributed a further £0.5 million, bringing the total invested to £2.0 million. The new funding will be used to provide working capital and to finance a significant growth phase in Xceleron’s development. Xceleron, a spin out from the University of York, is the world’s foremost company using the nanotechnology of... read more